Health Catalyst to Participate in Upcoming Investor Conference
18 Fevereiro 2025 - 10:00AM
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading
provider of data and analytics technology and services to
healthcare organizations, today announced that Dan Burton, Chief
Executive Officer, Jason Alger, Chief Financial Officer, Dan
LeSueur, Chief Operating Officer, and Jack Knight, Vice President
of Investor Relations, will participate in the Raymond James &
Associates’ 46th Annual Institutional Investors Conference, in
Orlando, FL. Health Catalyst will host a fireside chat presentation
on Tuesday, March 4, 2025, at 1:40 p.m. ET. The webcast link will
be available online at https://ir.healthcatalyst.com.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and
analytics technology and services that ignite smarter healthcare,
lighting the path to measurable clinical, financial, and
operational improvement. More than 1,000 organizations worldwide
rely on Health Catalyst's offerings, including our cloud-based
technology ecosystem Health Catalyst Ignite™, AI-enabled data and
analytics solutions, and expert services to drive meaningful
outcomes across hundreds of millions of patient records. Powered by
high-value data, standardized measures and registries, and deep
healthcare domain expertise, Ignite helps organizations transform
complex information into actionable insights. Backed by a
multi-decade mission and a proven track record of delivering
billions of dollars in measurable results, Health Catalyst
continues to serve as the catalyst for massive, measurable,
data-informed healthcare improvement and innovation.
Health Catalyst Investor Relations Contact:
Jack KnightVice President, Investor Relations+1 (855)
309-6800ir@healthcatalyst.com
Health Catalyst Media Contact:
Amanda FlandersSenior Vice President, Marketing and
Communicationsmedia@healthcatalyst.com
Health Catalyst (NASDAQ:HCAT)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Health Catalyst (NASDAQ:HCAT)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025